Moneycontrol
Moneycontrol PRO
Get App Open
In App
News on WhatsApp
News on WhatsApp
Go PRO Now
Open App
Success
Alert
Please select a Day.
Info

Welcure Drugs and Pharmaceuticals Ltd.

Sector : Healthcare | Industry : Pharmaceuticals & Drugs
xpert
Have a query? Talk to Experts LIVE
Add to

55/100
0.32
0.01 (3.23%)

As on 21 Apr, 2026 | 12:58

Day Range
0.30
0.32
L H
52 Week Range
0.23
1.44
L H
Volume
7,752,600
*
i

* BSE Market Depth (21 Apr 2026)

BUY SELL
QTY PRICE PRICE QTY
3687845 0.32 0.00 0
1612024 0.31 0.00 0
4210299 0.30 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
9510168 Total Total 0
Bid / Ask
0.32 / 0.00
Compare Stocks Advanced Chart
NSE
MC Essentials
59% Pass
MC Technicals
i
This represents current trend.Click here for disclaimer.
MC Insights

Average Financial Strength, Average Growth Trend Stock at Discounted Valuations

Financials
    Ownerships
      Industry Comparison
        Others
          Open 0.00
          Previous Close 0.00
          Volume 0.00
          Value (Lacs) 0.00
          VWAP 0.00
          Beta
          Mkt Cap (Rs. Cr.) 0
          High 0.00
          Low 0.00
          UC Limit 0.00
          LC Limit 0.00
          52 Week High 0.00
          52 Week Low 0.00
          Face Value 0.00
          All Time High 0.00
          All Time Low 0.00
          20D Avg Volume 0
          20D Avg Delivery(%) --
          Book Value Per Share --
          Dividend Yield --
          TTM EPS See historical trend 0.00
          TTM PE See historical trend --
          P/B See historical trend --
          Sector PE 0.00

          Advanced Chart

          Click here to expand
          xpert

          *Delayed by 20 seconds.

          Forecast                                                

          Earnings Forecast

          Actuals Estimates
          ANNUALLY 
          (Rs.) 

          Valuations

          Consensus Recommendations

          • Buy
          • Outperform
          • Hold
          • Underperform
          • Sell

          Hits/Misses

          QUARTERLY (Rs.)
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline

          MC Insights

          Stock Score

          55/100
          Average Financial Strength, Average Growth Trend Stock at Discounted Valuations

          Get detailed analysis with Moneycontrol Stock Insights.

          Get detailed analysis with Moneycontrol Stock Insights.

          Price
          • 77.78% away from 52 week high

          Financials
          Piotroski Score
          i

          indicates

          Industry Comparison
          • Market Cap - Below Median

          Shareholding Pattern
          • Promoter holding remains unchanged at 0.00% in Dec 2025 qtr.

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          ` Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          		--%
          1 Month
          		--%
          3 Months
          		--%
          YTD
          		--%
          1 Year
          		--%
          3 Years
          		--%
          Volume Analysis
          • Volume
          • Delivery

          SEASONALITY ANALYSIS

          10 out of 18 years Welcure Drugs and Pharmaceuticals has given negative returns in April.

          Month Max. Positive Change(%) Avg. Positive Change(%) Max. Negative Change(%) Avg. Negative Change(%) Average Change(%)
          April 33.33% 14.70% -29.21% (2022) -14.64% -1.60%
          Seasonality Analysis

          Forum

          Community Sentiments

          • 0% BUY
          • 100% SELL
          • 0% HOLD
          100%
          of moneycontrol users recommend selling Welcure Drugs

          What's your call on Welcure Drugs today?

          Read 0 investor views

          BUY SELL HOLD
          POST

          Broker Research

          No Data For Broker Research.

          Deals

          No Data For Block Deals.

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          15 Apr, 2026

          Share India Securities Limited

          Qty 10852665 Price 0.35 % Traded 0.90
          15 Apr, 2026

          Share India Securities Limited

          Qty 10852665 Price 0.35 % Traded 0.90
          15 Apr, 2026

          Satish Kumar Grandhi

          Qty 8290001 Price 0.34 % Traded 0.67
          19 Mar, 2026

          Share India Securities Limited

          Qty 6624510 Price 0.26 % Traded 0.56
          19 Mar, 2026

          Share India Securities Limited

          Qty 5925781 Price 0.25 % Traded 0.48
          04 Mar, 2026

          Saroj Kumar Kundu

          Qty 8117233 Price 0.29 % Traded 0.63
          04 Mar, 2026

          Share India Securities Limited

          Qty 7331244 Price 0.3 % Traded 0.59
          04 Mar, 2026

          Transglobal Securities Ltd.

          Qty 6710361 Price 0.3 % Traded 0.54

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          + Show More
          15 Apr, 2026

          share india securities limited

          Qty 10,852,665 Price 0.35 % Traded 0.00
          15 Apr, 2026

          share india securities limited

          Qty 10,852,665 Price 0.35 % Traded 0.00
          15 Apr, 2026

          satish kumar grandhi

          Qty 8,290,001 Price 0.34 % Traded 0.00
          19 Mar, 2026

          share india securities limited

          Qty 6,624,510 Price 0.26 % Traded 0.00
          19 Mar, 2026

          share india securities limited

          Qty 5,925,781 Price 0.25 % Traded 0.00
          4 Mar, 2026

          saroj kumar kundu

          Qty 8,117,233 Price 0.29 % Traded 0.00
          4 Mar, 2026

          share india securities limited

          Qty 7,331,244 Price 0.30 % Traded 0.00
          4 Mar, 2026

          transglobal securities ltd.

          Qty 6,710,361 Price 0.30 % Traded 0.00
          + Show More

          Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Detailed Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Detailed Financials

          Shareholding

          Summary
          See Top Holdings
          Trend

          About the Company

          Welcure Drugs & Pharmaceuticals Ltd is engaged in the business of manufacture and marketing of pharmaceuticals formulations in the form of tablets, capsules and dry syrups. The Company is manufacturing over hundred varieties of formulations including antibiotics, sulpha drugs, vitamins, analgesics, antipyretics, corticosteroids, anti-malarials, anti-dysentery, anti-tuberculosis, anti-diabetics, tranquilisers, sedatives and gastro intestinals. The product range of the company includes Brucure,Diclo-plus, Dimcinplus,Nimesulide,Nimagyltd (tongue dissolvent),Ibucure & Relaxon Forte,Coldrest, Alert10004 Coldhistex,Cezen & Cezen Forte, Cezen CD,Kuffwel,Diaroban,Wormicide,Welquin,Sarvo,etc.
          {"success":1,"data":{"address":{"address1":"Plot No. 55, \nOffice No- 104, First Floo","address2":"Vijay Block, \nLaxmi Nagar, \nEast Delhi,,","city":"New Delhi","state":"Delhi","pincode":"110092","telephone1":"","telephone2":"","fax1":"011-","fax2":"","email":"welcuredrugs227@gmail.com","web":"https:\/\/welcure.co.in"},"management":[{"name":"Chintan Didawala","designation":"Managing Director"},{"name":"Pradeep dnyaneshwar Terse","designation":"Ind. Non-Executive Director"},{"name":"Yogeshkumar Prajapati","designation":"Ind. Non-Executive Director"},{"name":"Bhumika Pradhan","designation":"Ind. Non-Executive Director"},{"name":"Ravi Thakor","designation":"Ind. Non-Executive Director"}],"registrars":{"name":"Skyline Financial Services (p) Ltd.","address1":"D-153\/A,1st Floor,","address2":"Okhla Industrial Area, Phase-1,","address3":"","address4":"","telephone":"011-26292682, 26292683, 30857575 (10 Lines)","fax":"011-30857562, 26292681","email":"grievances@skylinerta.com","internet":"http:\/\/www.skylinerta.com","city":"New Delhi","state":"Delhi","pincode":"110020"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"No"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"No"},{"name":"Nifty 200","value":"No"}],"details":{"bseId":"524661","nseId":"","series":"","isinid":"INE331C01025"}}}

          • Registered Office

          • Registrars

          • Management

            • Chintan Didawala

              Managing Director

            • Pradeep dnyaneshwar Terse

              Ind. Non-Executive Director

            • Yogeshkumar Prajapati

              Ind. Non-Executive Director

            • Bhumika Pradhan

              Ind. Non-Executive Director

            • Ravi Thakor

              Ind. Non-Executive Director

            + See More

          • Included In

            • BSE 100

              No

            • BSE 200

              No

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              No

            • Nifty 200

              No

          • Details

            • BSE:

              524661

            • NSE:

            • Series

            • ISIN

              INE331C01025

          Go to Top

          Advisory Alert:

          It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347